Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Sweden

Marie Skłodowska-Curie Action · Ended early

AquaDrugs Uncovering the effects of pharmaceuticals in the wild, beyond individuals to animal communities

Coordinator
Sveriges Lantbruksuniversitet, Sweden
Runs
1 January 2023 to 31 December 2024
Status
Ended early
EU funding
€223k
Total cost
—
Partners
2 organisations in 2 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101061889

What the project is doing

In the project's own words, from its summary on CORDIS.

The increasing production and release of pharmaceutical pollutants into waterways is now a leading threat to aquatic wildlife and ecosystems around the world. Despite this, knowledge on the hazards these contaminants cause in complex natural ecosystems is still extremely poor and thus considered an urgent research priority. AquaDrugs will harness new developments in underwater animal tracking and computer automation to identify how pharmaceutical waste in the environment can induce behavioural changes in animals that lead to high-order ecological effects.

Through a series of well-integrated experiments, and using fish as a model system, AquaDrugs will trace the impact of pharmaceuticals across biological scales to address four novel and ambitious objectives: (1) test how environmentally relevant concentrations of two globally pervasive pharmaceuticals (clobazam an tramadol), both in isolation and in a mixture, influence ecologically important wildlife behaviours and variability; (2) identify whether, and how, such changes impact animal collectives; (3) determine how pharmaceutical-induced behavioural changes at the individual and group levels scale up to shape aquatic communities; and (4) uncover how exposure shapes the ecological interactions of multiple species.

The project will deliver urgently needed data for chemicals regulation leading to improved policies that safeguard Europes aquatic ecosystems and wildlife from pharmaceutical impacts. The interdisciplinary approaches and theory in AquaDrugsfrom integrative ecology, ecotoxicology, and analytical chemistryalso promises to yield pioneering results and experimental innovations that will advance these scientific fields and boost the expertise and academic career of the research fellow, Dr Marcus Michelangeli.

Importantly, the research in AquaDrugs directly addresses key research priorities in Europe including the European Green Deal and the EUs Mission for Healthy Oceans, Seas, and Inland Waters.

Topics

Who is involved

OrganisationCityCountryRole
Sveriges LantbruksuniversitetUppsalaSwedenCoordinator
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften eVMunchenGermanyAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI